H10.513 Ligneous conjunctivitis, bilateral

Name of the Condition

• Ligneous conjunctivitis, bilateral

Summary

Ligneous conjunctivitis, bilateral, is a rare, chronic inflammatory disorder affecting both eyes. It is characterized by the formation of thick, fibrinous pseudomembranes on the conjunctival surfaces. The condition often presents with persistent redness, irritation, and discharge, and may involve other ocular structures. Symptoms typically include eyelid swelling, itching, and a gritty sensation, with both eyes being the primary sites of involvement.

Causes

Ligneous conjunctivitis is commonly associated with deficiencies in plasminogen or other fibrinolytic pathway abnormalities. Infections, such as bacterial or fungal, may also contribute. Allergic reactions to environmental triggers or irritants may play a role. In some cases, underlying systemic conditions like plasminogen deficiency or autoimmune disorders can drive inflammation.

Risk Factors

• Plasminogen deficiency or other fibrinolytic pathway abnormalities.
• Chronic ocular infections or inflammation.
• Exposure to allergens or irritants (e.g., chemicals, smoke).
• Pre-existing systemic conditions (e.g., autoimmune disorders).
• Compromised immune system or chronic eye irritation.

Symptoms

• Redness and swelling of the conjunctiva in both eyes.
• Itching, burning, or gritty sensation in both eyes.
• Thick, fibrinous pseudomembrane formation on the conjunctiva.
• Discharge (watery, mucous, or purulent).
• Eyelid swelling or crusting.

Diagnosis

Diagnosis is based on clinical evaluation, including a detailed eye examination to identify pseudomembranes and inflammation. Laboratory tests may assess plasminogen levels or rule out infections. Biopsy of the conjunctival membrane may confirm the diagnosis by identifying fibrinous material and inflammatory cells. Imaging or additional tests may be used to evaluate underlying systemic conditions.

Treatment Options

Treatment focuses on managing inflammation and addressing underlying causes. Topical or systemic anti-inflammatory medications (e.g., corticosteroids) may reduce symptoms. Antimicrobial therapy is used if infections are present. For plasminogen deficiency, replacement therapy or fibrinolytic agents may be considered. Surgical removal of pseudomembranes may be necessary in severe cases, though recurrence is common.

Prognosis and Follow-Up

Prognosis varies; the condition is often chronic and may recur despite treatment. Regular follow-up with an ophthalmologist is essential to monitor for complications and adjust therapy. Long-term management may be required to control symptoms and prevent vision-threatening issues.

Complications

• Corneal scarring or ulceration.
• Vision impairment due to membrane formation.
• Chronic eye pain or discomfort.
• Recurrent infections.
• Systemic involvement if underlying conditions are present.

Lifestyle & Prevention

• Avoid known allergens or irritants (e.g., smoke, chemicals).
• Practice good eye hygiene to reduce infection risk.
• Follow prescribed treatment regimens consistently.
• Use lubricating eye drops to alleviate dryness or irritation.
• Protect eyes from environmental triggers.

When to Seek Professional Help

Seek immediate medical attention if you experience sudden vision changes, severe eye pain, increased redness, or discharge. Regular check-ups are recommended for ongoing management of chronic symptoms or if treatments are ineffective.

Tips for Medical Coders

Document the bilateral nature of the condition clearly in the medical record. Ensure the diagnosis is supported by clinical findings, such as pseudomembrane presence or lab results confirming underlying causes. Code H10.513 is specific to bilateral involvement; verify documentation aligns with this specificity.